Lacosamide Injection
Product Images NDC 60505-6235

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 60505-6235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel.jpg (Cartonlabel)

Label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Apotex Corp. The package contains 10 single-dose vials of 20 mL each. The label includes usage instructions for intravenous use only and notes to dispense the enclosed medication guide to each patient. The label also provides manufacturer details and a barcode.*

FDA Label Image

Figure1.jpg (Figure1)

A bar chart illustrating seizure reduction as median percent change from baseline in three studies. Each study compares placebo and three doses of lacosamide (200, 400, 600 mg/day). The vertical axis ranges from 0% to 45%, with lacosamide doses showing higher seizure reduction percentages than placebo, marked by asterisks to indicate statistical significance.*

FDA Label Image

Figure2.jpg (Figure2)

A cumulative responder rate graph showing the percentage of patients versus responder rate (equal to or greater improvement). The graph compares placebo and three dosages of lacosamide injection (200 mg/day, 400 mg/day, 600 mg/day), displaying improvement trends for each group in a clinical study setting.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of lacosamide, showing its molecular arrangement with functional groups including amide and aromatic benzene ring components.*

FDA Label Image

Viallabel.jpg (Viallabel)

Label for Lacosamide Injection, USP 10 mg/mL (200 mg/20 mL) in a single-dose vial, for intravenous use only. The 20 mL vial is manufactured by Maiya Pharma Pvt. Ltd, India, and labeled for Apotex Corp, Weston, Florida. The label includes storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.